Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
99Tc-MDP vs Methylprednisolone for Active Moderate to Severe TAO
NCT03948191Phase 4Completed
- Sponsor
- Dalian University
- Start
- Oct 2017
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of technetium-99m-methylene diphosphonate in thyroid associated ophthalmopathy (TAO), sponsored by Dalian University. Started Oct 2017; status: completed.
02
Drugs
technetium-99m-methylene diphosphonate
03
Conditions
thyroid associated ophthalmopathy (TAO)
Beyond the preview
Go deeper on NCT03948191.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03948191.